Fresenius SE & Co. KGaA

GHA MEMBER PRESENTATION

Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany

www.fresenius.com

YOUR CONTACT PARTNER

Christoph Liesche

christoph.liesche@fresenius.com

Company / Organisation

Foundation: 1912

Founder: Dr. Eduard Fresenius

Holder: Fresenius SE & Co. KGaA

Revenue: €21,5 billion (2022)

Employees: 190,000 in more than 80 countries (2022)

Sales markets: Global - An international focus is one of the strengths of the Fresenius Group. Fresenius Kabi, Fresenius Helios and Fresenius Vamed operate successfully with their own subsidiaries and local units in more than 80 countries.

Business fields:

Generic Medicinal Products – Biosimilars - Infusion Therapy – Clinical Nutrition - Transfusion Technology – Hospitals (owns and operates Helios hospitals Germany /Quirónsalud hospitals in Spain), Projects and Provides services for hospitals and other healthcare facilities worldwide Health Prevention, Health Tourism

Brief Introduction:

Fresenius SEFresenius SE & Co. KGaA is a global healthcare company headquartered in Bad Homburg v. d. Höhe, Germany.

As a healthcare company focused on therapy, Fresenius offers system-critical products and services for leading therapies for the care of critically and chronically ill patients.

The Fresenius Group comprises the operating business segments Fresenius Kabi and Fresenius Helios as well as the investees Fresenius Medical Care and Fresenius Vamed.

With 145 hospitals and numerous outpatient facilities, Fresenius Helios is the leading private hospital operator in Germany and Spain, treating around 24 million patients every year. Fresenius Kabi offers drugs and medical technology for infusion, transfusion, and clinical nutrition worldwide.

SOLUTIONS | PRODUCTS | SERVICES:

Database currently updated.